Mejorar la calidad de vida y sobrevida de las personas con cánceres gastrointestinales, respetando su dignidad y autonomía en las fases de prevención, diagnóstico y tratamiento, por medio de acompañamiento, educación, información, investigación y abogacía. To improve the quality of life and survival of people with gastrointestinal cancers, respecting their dignity and autonomy in the […]
Chile, Fundación GIST Chile, GAD2017, GAD2017photos
We had a successful GIST Awareness Day meeting on 8th July 2017 in Tata Memorial hospital in Mumbai. It was attended by Dr. P Jagannath (Chairman, Department of Surgical Oncology, Lilavati Hospital and Research Centre, Mumbai) and Dr. Vikram Chaudhari from the Department of Surgical Oncology, Tata Memorial Hospital and GIST patients. All the materials […]
GAD2017, GAD2017photos, GIST patients, Mumbai, Tata Memorial Hospital
The latest edition of the GIST and Sarcoma Journal is now available online. The GIST and Sarcoma Journal is a comprehensive and authoritative resource for scientifically valid information for physicians, allied healthcare professionals and the patient community regarding advances in the diagnosis and treatment of gastrointestinal stromal tumors and other sarcomas. In the latest issue, […]
Dr. Jonathan Trent, GIST and Sarcoma Journal, GIST Education, GIST research, liquid biopsy, National Leiomyosarcoma Foundation, New York Presbyterian/Columbia University Medical Center, SarcomaA significant finding from a newly published study in JAMA Oncology, indicates that nearly one-fourth of GIST patients with advanced disease initially treated with imatinib will survive for ten years or more. The study, a follow-up of a randomized clinical trial of 695 adult GIST patients, was coordinated by SWOG, with participation from member and […]
Clinical Trial, Dr. Michael Heinrich, GIST research, Gleevec, imatinib, JAMA Oncology, KIT exon 11, research, SWOG